Synthesis of Nitazoxanide Derivatives as Potent and Orally Available HBx-DDB1 Inhibitors against Hepatitis B Virus

  • Kim, Seong Gon; 
  • Cha, Hyeon-Min; 
  • Kim, Minwoo; 
  • Jo, Inseong; 
  • Han, Soo Bong; 
  • 외 5명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Nitazoxanide-based analogues were synthesized and evaluated for HBx-DDB1 interaction inhibition using a split-luciferase assay. Compared to the nitazoxanide (NTZ, IC50 = 1.2 mu M) the compound 49a exhibited potent inhibition of the HBx-DDB1 interaction with an IC50 of 0.083 mu M. Consistent with its HBx-DDB1 inhibitory effect, compound 49a showed antiviral activity in HBV-infected cells. Compound 49a displayed excellent metabolic stability in human liver microsomes (82% remaining after 30 min), minimal hERG inhibition, and limited CYP interference, showing only moderate inhibition of CYP2C9. In vivo pharmacokinetic studies in mice and rats revealed rapid absorption (T-max = 0.5-3.5 h), low systemic clearance (0.09-0.10 L/h/kg), and high oral bioavailability (>90%). These findings establish compound 49a as a promising lead for the development of direct-acting antivirals targeting chronic HBV infection.

키워드

Hepatitis B virus; HBx-DDB1 interaction; Antiviralagent; ADMET; PK; X PROTEIN; TRANSCRIPTION; REPLICATION; SMC5/6
제목
Synthesis of Nitazoxanide Derivatives as Potent and Orally Available HBx-DDB1 Inhibitors against Hepatitis B Virus
저자
Kim, Seong Gon; Cha, Hyeon-Min; Kim, Minwoo; Jo, Inseong; Han, Soo Bong; Kim, Meehyein; Park, Wonseo; Kim, Youyoung; Ko, Chunkyu; Kim, Dong-Su
DOI
10.1021/acsmedchemlett.6c00101
발행일
2026-06
유형
Article; Early Access
저널명
ACS Medicinal Chemistry Letters
권
17
호
7
페이지
1539 ~ 1546